This article is more than 5 years old. Information may no longer be current.
CMHC names four to Senior Planning Committee
Click Here to Manage Email Alerts
The Cardiometabolic Health Congress announced that four experts have been appointed as members of its Senior Planning Committee for the 2017-2018 CMHC educational curriculum.
The committee will work with the CMHC chairpersons to lead the planning and development of the congress’ educational objectives and approach.
According to a press release by the CMHC, each member brings a unique therapeutic expertise in clinical research to the scientifically independent CMHC educational curriculum.
The members of the Senior Planning Committee are as follows:
Deepak L. Bhatt, MD, MPH, chief of cardiology at VA Boston Healthcare System, director of the Integrated Interventional Cardiovascular Program at Brigham and Women’s Hospital and VA Boston Healthcare System, senior investigator in the TIMI Study Group, professor of medicine at Harvard Medical School and chief medical editor of Cardiology Today’s Intervention, has authored and co-authored over 500 publications, serves on several editorial boards, and has lectured worldwide on topics from premature CAD to the role of inflammation and genetics in MI.
Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA, professor of medicine at Tulane University School of Medicine and Tulane Heart and Vascular Institute, New Orleans, and a member of the Cardiology Today Editorial Board, is an American Society of Hypertension-certified specialist in clinical hypertension. He is past chair of the National Forum for Heart Disease and Stroke Prevention and past chair and chief science officer of ASH.
JoAnn Lindenfeld, MD, is director of the heart failure and transplantation programs at Vanderbilt University and past president of the Heart Failure Society of America. She has decades of experience in large multicenter randomized clinical trials in HF and heart transplantation.
Clyde W. Yancy, MD, MSc, MACP, FAHA, professor of medicine and medical social science, chief of cardiology, associate director of the Bluhm CV Institute and vice dean of diversity and inclusion at Northwestern University Feinberg School of Medicine, and past president of the American Heart Association, has received many accolades for clinical research and expertise in the field of HF, and has an written numerous peer-reviewed manuscripts, book chapters, and editorials.
Disclosure: Bhatt reports financial ties with various device and pharmaceutical companies. Ferdinand and Yancy report no relevant financial disclosures. Lindenfeld reports financial ties with Novartis.